Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bram Volckaert"'
Autor:
Nicolas Poirier, Irène Baccelli, Lyssia Belarif, Riad Abès, Géraldine Teppaz, Caroline Mary, Sonia Poli, Claudia Fromond, Isabelle Girault, Sabrina Pengam, Emilienne Soma, Fanny De Sa, Jean-Pascal Conduzorgues, Cécile Braudeau, Regis Josien, Bram Volckaert, Dominique Costantini, Frédérique Corallo
Publikováno v:
The Journal of Immunology. 210:753-763
OSE-127 is a humanized mAb targeting the IL-7Rα-chain (CD127), under development for inflammatory and autoimmune disease treatment. It is a strict antagonist of the IL-7R pathway, is not internalized by target cells, and is noncytotoxic. In this wor
Autor:
Douglas G. Johns, Louis-Charles Campeau, Puja Banka, An Bautmans, Tjerk Bueters, Elisabetta Bianchi, Danila Branca, Paul G. Bulger, Inne Crevecoeur, Fa-Xiang Ding, Robert M. Garbaccio, Erik D. Guetschow, Yan Guo, Sookhee N. Ha, Jennifer M. Johnston, Hubert Josien, Eunkyung A. Kauh, Kenneth A. Koeplinger, Jeffrey T. Kuethe, Eseng Lai, Christine L. Lanning, Anita Y.H. Lee, Li Li, Anilkumar G. Nair, Edward A. O’Neill, S. Aubrey Stoch, David A. Thaisrivongs, Thomas J. Tucker, Petr Vachal, Kristien van Dyck, Frederic P. Vanhoutte, Bram Volckaert, Dennis G. Wolford, Andy Xu, Tian Zhao, Dan Zhou, Susan Zhou, Xiaohong Zhu, Hratch J. Zokian, Abbas Walji, Harold B. Wood
Publikováno v:
Circulation.
Background: Inhibition of PCSK9 (proprotein convertase subtilisin/kexin type 9)-low density lipoprotein receptor interaction with injectable monoclonal antibodies or small interfering RNA lowers plasma low density lipoprotein-cholesterol, but despite
Autor:
Roger Aitchison, Joseph J. Eiden, Kathleen L. Coelingh, Bram Volckaert, Gabriele Neumann, Oleg Rudenko, David Marshall, Robert B. Belshe, Yoshihiro Kawaoka, Renee Herber, Harry B. Greenberg, Pamuk Bilsel
Publikováno v:
The Journal of Infectious Diseases. 226:83-90
Background Current influenza vaccines are strain specific and demonstrate low vaccine efficacy against H3N2 influenza disease, especially when vaccine is mismatched to circulating virus. The novel influenza vaccine candidate, M2-deficient single repl
Autor:
Jamie M. Orengo, Sylvie Rottey, Natalie De Ruyck, Amanda Atanasio, Lorah Perlee, Meagan P. O'Brien, Jan de Hoon, Divya Ramesh, Bram Volckaert, Kristof Lesneuck, Hisham Abdallah, Mohamed A. Kamal, David M. Weinreich, Jarno De Craemer, Michelle DeVeaux, George D. Yancopoulos, Claire Q. Wang, Philippe Gevaert, Gary Herman, Robert Dingman, Peter Hellings, Vishal Kamat
Publikováno v:
Journal of allergy and clinical immunology, 149(1), 189-199. Mosby Inc.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
BACKGROUND: The efficacy of an allergen-specific IgG cocktail to treat cat allergy suggests that allergen-specific IgG may be a major protective mechanism elicited by allergen immunotherapy. OBJECTIVES: Extending these findings, we tested a Bet v 1-s
Autor:
Haiko Pillu, Robert Lins, Bram Volckaert, Muriel Lins, Arash Ghalamkarpour, Katrien Timmermans
Publikováno v:
Airway pharmacology and treatment.
Autor:
Ruth Ellis, Yoshihiro Kawaoka, Pamuk Bilsel, Harry B. Greenberg, Gabriele Neumann, Bram Volckaert, Oleg Rudenko, Robert B. Belshe, Roger Aitchison, Renee Herber, Kathleen L. Coelingh, Joseph Eiden
Publikováno v:
Open Forum Infectious Diseases
Background Demonstration of protection by a M2SR (M2 deficient Single Replication) monovalent H3N2 vaccine was assessed in a phase 2a clinical trial in which the challenge virus was substantially drifted from the vaccine. M2SR is an investigational,